Buys
Open market- Shares
- +6,146
- Avg price
- $4.88
- Total value
- +$29,992
Anthony James Culverwell - Director at Quoin Pharmaceuticals, Ltd.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- QNRX on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Anthony James Culverwell in Quoin Pharmaceuticals, Ltd.
Sells
Open market- Shares
- Avg price
- Total value
Net
Past year- Shares
- +6,146
- Share %
- 100%
- Total value
- +$29,992
Reported holdings for Anthony James Culverwell in Quoin Pharmaceuticals, Ltd.
Form 4 holding
Director
Quoin Pharmaceuticals, Ltd.
- Security class
- ADSs
- Shares / value
- 40,364
- Estimated value
- $196,976
- Report date
- 31 Aug 2026
- Price
- $4.88
- Ownership
- Direct
Form 4 holding
Director
Quoin Pharmaceuticals, Ltd.
- Security class
- Share Option (Right to Buy)
- Shares / value
- 21,709
- Estimated value
- Report date
- 04 Feb 2026
- Price
- Ownership
- Direct
- Underlying class
- ADS
- Underlying amount
Form 4 holding
Director
Quoin Pharmaceuticals, Ltd.
- Security class
- Ordinary Warrants (Right to Buy)
- Shares / value
- 3,073
- Estimated value
- Report date
- 31 Aug 2026
- Price
- Ownership
- Direct
- Underlying class
- ADS
- Underlying amount
Transaction history for Anthony James Culverwell in Quoin Pharmaceuticals, Ltd.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.